Venus Concept Inc (VERO) Stock
VERO is no longer traded. Venus Concept was delisted from the Nasdaq in April 2026.
Prices on this page are historical; the last trade was April 6, 2026 at $0.31.
Venus Concept stock price history
VERO final trading statistics
- Final close
- $0.31
- Final trading day
- Apr 6, 2026
- Market cap at delisting
- $578.2K
- Shares outstanding
- 1.86M
- Final 52-week range
- $0.25 – $14.50
- Avg. volume (final 3 mo.)
- 5,793,560
- All-time high (split-adj.)
- $24552.03 · Oct 2017
- All-time low (split-adj.)
- $0.30 · Apr 2026
- Return since IPO
- -100.0%
- Beta
- -0.06
- Book value / share
- $1.44
- Price / book
- 0.22
Venus Concept annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $64.83M | -$47.0M | -$17.17 |
| FY2023 | $76.35M | -$37.2M | -$6.85 |
| FY2022 | $99.50M | -$43.7M | -$0.65 |
| FY2021 | $105.62M | -$22.1M | -$0.47 |
| FY2020 | $78.01M | -$82.8M | -$1.64 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Venus Concept Inc
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Venus Concept stock FAQ
What happened to Venus Concept stock?
Venus Concept stock was delisted from the Nasdaq. Its final close was $0.31 on April 6, 2026.
Is VERO stock still trading?
No. VERO was delisted from the Nasdaq in April 2026 and no longer trades on a U.S. exchange.
What was the last price of VERO stock?
VERO closed at $0.31 on its final trading day, April 6, 2026, for a market value of about $578.2K.
What were Venus Concept's revenue and earnings in its last full fiscal year?
Venus Concept reported revenue of $64.83M and net income of -$47.0M in fiscal 2024, its last full year as a public company.
When did Venus Concept go public?
Venus Concept Inc stock began trading on November 5, 2012.